Literature DB >> 27896624

Autologous bone marrow stem cell transplantation for the treatment of ulcerative colitis complicated with herpes zoster: a case report.

Hang Xiang1, Xiaomei Zhang1, Chao Yang2, Wenhuan Xu1, Xin Ge3, Rong Zhang2, Ya Qiu1, Wanjun Sun2, Fan Li1, Tianyuan Xiang4, Haixu Chen5, Zheng Wang6, Qiang Zeng7.   

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with continuous or recurrent symptoms. A 42-year-old male patient with intermittent diarrhea accompanied by bloody mucopurulent stools was admitted to our hospital. The diagnosis of UC was confirmed by a combination of laboratory examination, colonoscopy, and histological assay. The patient developed herpes zoster in the hospital, which challenged traditional treatments. Therefore, we performed an autologous bone marrow cells to modulate the immune system with his permission. Autologous bone marrow mononuclear cells were collected and injected locally into the bowel mucosa, and subsequently injected systemically through a peripheral vein. After the patient underwent auto bone marrow mononuclear cells transplantations twice, the patient's symptoms were alleviated. Furthermore, he recovered from hematochezia, and his hypersensitive C reactive protein decreased. Colonoscopy results showed reduced lesions and decreased areas with bleeding and edema in the sigmoid colon and rectum. No recurrence occurred in the subsequent two years, but long-time monitoring is still necessary for the prophylaxis of colorectal cancer.

Entities:  

Keywords:  autograft; bone marrow stem cells; cell therapy; ulcerative colitis

Mesh:

Year:  2016        PMID: 27896624     DOI: 10.1007/s11684-016-0485-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  27 in total

1.  Oversight for clinical uses of autologous adult stem cells: lessons from international regulations.

Authors:  Tamra Lysaght; Ian Kerridge; Douglas Sipp; Gerard Porter; Benjamin J Capps
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633

2.  Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I.

Authors:  E Snarski; A Milczarczyk; T Torosian; M Paluszewska; E Urbanowska; M Król; P Boguradzki; K Jedynasty; E Franek; W Wiktor-Jedrzejczak
Journal:  Bone Marrow Transplant       Date:  2010-06-28       Impact factor: 5.483

Review 3.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R B Sartor
Journal:  Gastroenterol Clin North Am       Date:  1995-09       Impact factor: 3.806

4.  Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.

Authors:  Xiao-Wen He; Xiao-Sheng He; Lei Lian; Xiao-Jian Wu; Ping Lan
Journal:  Dig Dis Sci       Date:  2012-06-30       Impact factor: 3.199

5.  Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells.

Authors:  Emilian Snarski; Tigran Torosian; Monika Paluszewska; Elzbieta Urbanowska; Alicja Milczarczyk; Krystyna Jedynasty; Edward Franek; Wiesław Wiktor Jedrzejczak
Journal:  Pol Arch Med Wewn       Date:  2009-06

6.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  [Complete elimination of cytomegalovirus without antiviral therapy after systemic transplantation of mesenchymal bone marrow stromal cells in a patient with ulcerative colitis].

Authors:  O V Kniazev; I N Ruchkina; A I Parfenov; A G Konopliannikov; V E Sagynbaeva
Journal:  Eksp Klin Gastroenterol       Date:  2012

8.  Manganese superoxide dismutase gene therapy protects against irradiation- induced intestinal injury.

Authors:  Chao Yang; Hai-Xu Chen; Yong Zhou; Min-Xia Liu; Yan Wang; Jie-Xi Wang; Su-Ping Ren; Ying Han; Ben-Yan Wu
Journal:  Curr Gene Ther       Date:  2013-10       Impact factor: 4.391

9.  Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model.

Authors:  Yaming Wei; Yuqiang Nie; Jieying Lai; Yu-Jui Yvonne Wan; Yuyuan Li
Journal:  Transplantation       Date:  2009-07-15       Impact factor: 4.939

10.  Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.

Authors:  Francesca D'Addio; Alessandro Valderrama Vasquez; Moufida Ben Nasr; Edward Franek; Dalong Zhu; Lirong Li; Guang Ning; Emilian Snarski; Paolo Fiorina
Journal:  Diabetes       Date:  2014-06-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.